Periprosthetic Fracture Registry (PPFx)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAO Innovation Translation Center
About this trial
This registry supports international data collection and research on PPFx treatments after hip and knee arthroplasty.
A registry such as this ultimately aims to provide far-reaching benefits to society including reduced morbidity and mortality, improved patient safety, improved quality of care and medical decision-making, reduced medical spending, and advances in orthopaedic science.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥18 years
Post-operative PPFx after total or hemi hip or total or unicondylar knee arthroplasty (including the acetabulum, femur, patella and proximal tibia) requiring
osteosynthesis alone or
component revision plus plate/nail osteosynthesis
Disqualifiers
Pregnancy or women planning to conceive within the study period
Prisoner
Trial population
Patients with total or hemi hip or knee arthroplasty and who have a fracture around one of the arthroplasty
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Classification of the fracture
Classification of the fracture using the UCS and some parts of the AO/OTA fracture classification system.
Time frame
Pre-operatively (Day -1)Secondary outcomes
1
Fracture mechanism
High / low energy trauma, pathological fracture, stem stability
Time frame
Pre-operatively (Day -1)2
Rehabilitation program
weight bearing, bedrest, splint
Time frame
Up to 12 months3
Function of hip or knee
Harris Hip Score or Knee Society score
Time frame
Up to 12 months4
Health related quality of life
PROMIS pain interference and physical activity
Time frame
Up to 12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov